, /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: ) today announced that it will report its 2024 second quarter financial results on , after the close of the U.S. financial markets.
Company management will host a live audio webcast at / to discuss 2024 second quarter financial results and provide a business and financial update. U.S.
Dial-In Number: +1 800 715 9871 Ireland Dial-In Number: +353 1800 943 926 Additional global dial-in numbers are available . Passcode: 9124647 Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at . To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.
A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at . Jazz Pharmaceuticals plc (Nasdaq: ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options.
We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dub.
